The positive regulation of CLCA1 and CES2 were both lost from normal to cancer, and thus may result in reduced expression of two targets, which could further inhibit proliferation or induce apoptosis (Li et al. 2017b; Shaojun et al. 2018) (Additional file 4: Fig. S4C). The gene discussed is CLCA1; the disease is cancer.